Omalizumab as Third-Line Therapy for Urticaria During Pregnancy

J Investig Allergol Clin Immunol. 2017;27(5):326-327. doi: 10.18176/jiaci.0179.
No abstract available

Keywords: Angioedema; Omalizumab; Therapeutics; Urticaria.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Allergic Agents / therapeutic use*
  • Female
  • Humans
  • Omalizumab / therapeutic use*
  • Pregnancy
  • Pregnancy Complications*
  • Risk Factors
  • Symptom Assessment
  • Treatment Outcome
  • Urticaria / diagnosis
  • Urticaria / drug therapy*

Substances

  • Anti-Allergic Agents
  • Omalizumab